[Federal Register Volume 77, Number 136 (Monday, July 16, 2012)]
[Notices]
[Page 41789]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17313]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Department of Health and Human Services, Office of the
Assistant Secretary for Health, Presidential Commission for the Study
of Bioethical Issues.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
will conduct its tenth meeting in August. At this meeting, the
Commission will continue discussing topics related to the ethical
issues associated with the development of medical countermeasures for
children. The Commission will also develop and finalize recommendations
regarding access to, and privacy of human genome sequence data.
DATES: The meeting will take place Wednesday and Thursday, August 1-2,
2012.
ADDRESSES: Renaissance Washington, DC Downtown Hotel, 999 9th Street
NW., Washington, DC 20001. Telephone (202) 898-9000.
FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications
Director, Presidential Commission for the Study of Bioethical Issues,
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone:
202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional
information may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given
of the tenth meeting of the Presidential Commission for the Study of
Bioethical Issues (the Commission). The meeting will be held from 9
a.m. to approximately 5:30 p.m. on Wednesday, August 1, 2012, and from
9 a.m. to approximately 4 p.m. on Thursday, August 2, 2012, in
Washington, DC. The meeting will be open to the public with attendance
limited to space available. The meeting will also be webcast at
www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the Commission. The Commission is an advisory
panel of the nation's leaders in medicine, science, ethics, religion,
law, and engineering. The Commission advises the President on
bioethical issues arising from advances in biomedicine and related
areas of science and technology. The Commission seeks to identify and
promote policies and practices that ensure scientific research, health
care delivery, and technological innovation are conducted in a socially
and ethically responsible manner.
The main agenda item for the Commission's tenth meeting is to
continue discussing topics related to the ethical issues associated
with the development of medical countermeasures for children. The
Commission will also develop and finalize recommendations regarding
access to, and privacy of human genome sequence data.
The draft meeting agenda and other information about PCSBI,
including information about access to the webcast, will be available at
www.bioethics.gov.
The Commission welcomes input from anyone wishing to provide public
comment on any issue before it. Respectful debate of opposing views and
active participation by citizens in public exchange of ideas enhances
overall public understanding of the issues at hand and conclusions
reached by the Commission. The Commission is particularly interested in
receiving comments and questions during the meeting that are responsive
to specific sessions. Written comments will be accepted at the
registration desk and comment forms will be provided to members of the
public in order to write down questions and comments for the Commission
as they arise. To accommodate as many individuals as possible, the time
for each question or comment may be limited. If the number of
individuals wishing to pose a question or make a comment is greater
than can reasonably be accommodated during the scheduled meeting, the
Commission may make a random selection.
Anyone planning to attend the meeting who needs special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting.
The Commission will make every effort to accommodate persons who need
special assistance.
Written comments will also be accepted in advance of the meeting
and are especially welcome. Please address written comments by email to
info@bioethics.gov, or by mail to the following address: Public
Commentary, Presidential Commission for the Study of Bioethical Issues,
1425 New York Ave. NW., Suite C-100, Washington, DC 20005. Comments
will be publicly available, including any personally identifiable or
confidential business information that they contain. Trade secrets
should not be submitted.
Dated: July 9, 2012.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical
Issues.
[FR Doc. 2012-17313 Filed 7-13-12; 8:45 am]
BILLING CODE 4154-06-P